nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.0061	0.0061	CcSEcCtD
Zanamivir—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00607	0.00607	CcSEcCtD
Zanamivir—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00574	0.00574	CcSEcCtD
Zanamivir—Neutropenia—Dactinomycin—uterine cancer	0.00553	0.00553	CcSEcCtD
Zanamivir—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00544	0.00544	CcSEcCtD
Zanamivir—Ill-defined disorder—Progesterone—uterine cancer	0.00541	0.00541	CcSEcCtD
Zanamivir—Lung disorder—Epirubicin—uterine cancer	0.0054	0.0054	CcSEcCtD
Zanamivir—Malaise—Progesterone—uterine cancer	0.00526	0.00526	CcSEcCtD
Zanamivir—Syncope—Progesterone—uterine cancer	0.00523	0.00523	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00523	0.00523	CcSEcCtD
Zanamivir—Loss of consciousness—Progesterone—uterine cancer	0.00512	0.00512	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Etoposide—uterine cancer	0.00512	0.00512	CcSEcCtD
Zanamivir—Cough—Progesterone—uterine cancer	0.00509	0.00509	CcSEcCtD
Zanamivir—Convulsion—Progesterone—uterine cancer	0.00505	0.00505	CcSEcCtD
Zanamivir—Lung disorder—Doxorubicin—uterine cancer	0.005	0.005	CcSEcCtD
Zanamivir—Myalgia—Progesterone—uterine cancer	0.00496	0.00496	CcSEcCtD
Zanamivir—Arthralgia—Progesterone—uterine cancer	0.00496	0.00496	CcSEcCtD
Zanamivir—Anxiety—Progesterone—uterine cancer	0.00495	0.00495	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00493	0.00493	CcSEcCtD
Zanamivir—Discomfort—Progesterone—uterine cancer	0.0049	0.0049	CcSEcCtD
Zanamivir—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.0049	0.0049	CcSEcCtD
Zanamivir—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.00485	CcSEcCtD
Zanamivir—Confusional state—Progesterone—uterine cancer	0.0048	0.0048	CcSEcCtD
Zanamivir—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00476	0.00476	CcSEcCtD
Zanamivir—Anaphylactic shock—Progesterone—uterine cancer	0.00476	0.00476	CcSEcCtD
Zanamivir—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.00474	CcSEcCtD
Zanamivir—Infection—Progesterone—uterine cancer	0.00473	0.00473	CcSEcCtD
Zanamivir—Shock—Progesterone—uterine cancer	0.00468	0.00468	CcSEcCtD
Zanamivir—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.00464	CcSEcCtD
Zanamivir—Skin disorder—Progesterone—uterine cancer	0.00462	0.00462	CcSEcCtD
Zanamivir—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.00458	CcSEcCtD
Zanamivir—Anorexia—Progesterone—uterine cancer	0.00453	0.00453	CcSEcCtD
Zanamivir—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.0045	0.0045	CcSEcCtD
Zanamivir—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0045	0.0045	CcSEcCtD
Zanamivir—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00448	0.00448	CcSEcCtD
Zanamivir—Erythema multiforme—Dactinomycin—uterine cancer	0.00447	0.00447	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00447	0.00447	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00446	0.00446	CcSEcCtD
Zanamivir—Delirium—Epirubicin—uterine cancer	0.00445	0.00445	CcSEcCtD
Zanamivir—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00444	0.00444	CcSEcCtD
Zanamivir—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00435	0.00435	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00433	0.00433	CcSEcCtD
Zanamivir—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00431	0.00431	CcSEcCtD
Zanamivir—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00428	CcSEcCtD
Zanamivir—Chills—Dactinomycin—uterine cancer	0.00425	0.00425	CcSEcCtD
Zanamivir—Dyspnoea—Progesterone—uterine cancer	0.00424	0.00424	CcSEcCtD
Zanamivir—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.00424	CcSEcCtD
Zanamivir—Bronchospasm—Etoposide—uterine cancer	0.00421	0.00421	CcSEcCtD
Zanamivir—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00419	0.00419	CcSEcCtD
Zanamivir—Decreased appetite—Progesterone—uterine cancer	0.00414	0.00414	CcSEcCtD
Zanamivir—Delirium—Doxorubicin—uterine cancer	0.00411	0.00411	CcSEcCtD
Zanamivir—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00411	0.00411	CcSEcCtD
Zanamivir—Fatigue—Progesterone—uterine cancer	0.0041	0.0041	CcSEcCtD
Zanamivir—Pain—Progesterone—uterine cancer	0.00407	0.00407	CcSEcCtD
Zanamivir—Neutropenia—Etoposide—uterine cancer	0.004	0.004	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00393	0.00393	CcSEcCtD
Zanamivir—Feeling abnormal—Progesterone—uterine cancer	0.00392	0.00392	CcSEcCtD
Zanamivir—Gastrointestinal pain—Progesterone—uterine cancer	0.00389	0.00389	CcSEcCtD
Zanamivir—Musculoskeletal pain—Epirubicin—uterine cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.00384	CcSEcCtD
Zanamivir—Ill-defined disorder—Dactinomycin—uterine cancer	0.00382	0.00382	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00378	0.00378	CcSEcCtD
Zanamivir—Urticaria—Progesterone—uterine cancer	0.00378	0.00378	CcSEcCtD
Zanamivir—Abdominal pain—Progesterone—uterine cancer	0.00376	0.00376	CcSEcCtD
Zanamivir—Body temperature increased—Progesterone—uterine cancer	0.00376	0.00376	CcSEcCtD
Zanamivir—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00375	0.00375	CcSEcCtD
Zanamivir—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00372	CcSEcCtD
Zanamivir—Malaise—Dactinomycin—uterine cancer	0.00372	0.00372	CcSEcCtD
Zanamivir—Influenza like illness—Epirubicin—uterine cancer	0.00371	0.00371	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—uterine cancer	0.00358	0.00358	CcSEcCtD
Zanamivir—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00352	0.00352	CcSEcCtD
Zanamivir—Myalgia—Dactinomycin—uterine cancer	0.00351	0.00351	CcSEcCtD
Zanamivir—Hypersensitivity—Progesterone—uterine cancer	0.0035	0.0035	CcSEcCtD
Zanamivir—Discomfort—Dactinomycin—uterine cancer	0.00347	0.00347	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—uterine cancer	0.00344	0.00344	CcSEcCtD
Zanamivir—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00342	0.00342	CcSEcCtD
Zanamivir—Asthenia—Progesterone—uterine cancer	0.00341	0.00341	CcSEcCtD
Zanamivir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00341	CcSEcCtD
Zanamivir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00341	CcSEcCtD
Zanamivir—Infection—Dactinomycin—uterine cancer	0.00334	0.00334	CcSEcCtD
Zanamivir—Diarrhoea—Progesterone—uterine cancer	0.00325	0.00325	CcSEcCtD
Zanamivir—Erythema multiforme—Etoposide—uterine cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Anorexia—Dactinomycin—uterine cancer	0.0032	0.0032	CcSEcCtD
Zanamivir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.00318	CcSEcCtD
Zanamivir—Dizziness—Progesterone—uterine cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.00309	CcSEcCtD
Zanamivir—Chills—Etoposide—uterine cancer	0.00307	0.00307	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00306	0.00306	CcSEcCtD
Zanamivir—Vomiting—Progesterone—uterine cancer	0.00302	0.00302	CcSEcCtD
Zanamivir—Rash—Progesterone—uterine cancer	0.003	0.003	CcSEcCtD
Zanamivir—Dermatitis—Progesterone—uterine cancer	0.003	0.003	CcSEcCtD
Zanamivir—Headache—Progesterone—uterine cancer	0.00298	0.00298	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—uterine cancer	0.00295	0.00295	CcSEcCtD
Zanamivir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00295	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—uterine cancer	0.00292	0.00292	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—uterine cancer	0.0029	0.0029	CcSEcCtD
Zanamivir—Pain—Dactinomycin—uterine cancer	0.00288	0.00288	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00287	0.00287	CcSEcCtD
Zanamivir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00285	0.00285	CcSEcCtD
Zanamivir—Nausea—Progesterone—uterine cancer	0.00283	0.00283	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—uterine cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—uterine cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00275	0.00275	CcSEcCtD
Zanamivir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—uterine cancer	0.00273	0.00273	CcSEcCtD
Zanamivir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Malaise—Etoposide—uterine cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—uterine cancer	0.00268	0.00268	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—uterine cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—uterine cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00265	0.00265	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—uterine cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Cough—Etoposide—uterine cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Convulsion—Etoposide—uterine cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—uterine cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.00256	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Discomfort—Etoposide—uterine cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—uterine cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—uterine cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Confusional state—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—uterine cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Infection—Etoposide—uterine cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—uterine cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Influenza—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Asthma—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—uterine cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—uterine cancer	0.00236	0.00236	CcSEcCtD
Zanamivir—Anorexia—Etoposide—uterine cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—uterine cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—uterine cancer	0.00217	0.00217	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—uterine cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Rash—Dactinomycin—uterine cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—uterine cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Fatigue—Etoposide—uterine cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Pain—Etoposide—uterine cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—uterine cancer	0.00201	0.00201	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—uterine cancer	0.00201	0.00201	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—uterine cancer	0.002	0.002	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—uterine cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Urticaria—Etoposide—uterine cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—uterine cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—uterine cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—uterine cancer	0.00186	0.00186	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—uterine cancer	0.00182	0.00182	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—uterine cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Asthenia—Etoposide—uterine cancer	0.00175	0.00175	CcSEcCtD
Zanamivir—Chills—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—uterine cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Dizziness—Etoposide—uterine cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Chills—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Vomiting—Etoposide—uterine cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Agitation—Epirubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Rash—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Headache—Etoposide—uterine cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Malaise—Epirubicin—uterine cancer	0.00151	0.00151	CcSEcCtD
Zanamivir—Syncope—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Cough—Epirubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Nausea—Etoposide—uterine cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Infection—Epirubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Cough—Doxorubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Shock—Epirubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Infection—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Shock—Doxorubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Pain—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Pain—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—uterine cancer	0.001	0.001	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—uterine cancer	0.000933	0.000933	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—uterine cancer	0.00093	0.00093	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—uterine cancer	0.000906	0.000906	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—uterine cancer	0.000902	0.000902	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—uterine cancer	0.000867	0.000867	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—uterine cancer	0.000864	0.000864	CcSEcCtD
Zanamivir—Rash—Epirubicin—uterine cancer	0.00086	0.00086	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—uterine cancer	0.000859	0.000859	CcSEcCtD
Zanamivir—Headache—Epirubicin—uterine cancer	0.000855	0.000855	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—uterine cancer	0.000835	0.000835	CcSEcCtD
Zanamivir—Nausea—Epirubicin—uterine cancer	0.00081	0.00081	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—uterine cancer	0.000802	0.000802	CcSEcCtD
Zanamivir—Rash—Doxorubicin—uterine cancer	0.000796	0.000796	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—uterine cancer	0.000795	0.000795	CcSEcCtD
Zanamivir—Headache—Doxorubicin—uterine cancer	0.000791	0.000791	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—uterine cancer	0.00075	0.00075	CcSEcCtD
